Jens Schmidt
Overview
Explore the profile of Jens Schmidt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
4331
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Badrising U, Henderson R, Reddel S, Corbett A, Liang C, Reardon K, et al.
Clin Exp Rheumatol
. 2025 Feb;
43(2):316-325.
PMID: 40018746
Objectives: Inclusion body myositis (IBM) is a complex inflammatory muscle disease in adults over 40, with histological features of autoinflammation, cell stress and autophagic abnormalities, and marked clinically by relentless...
2.
Fattorini F, Conticini E, Dourado E, Bottazzi F, Bruno L, Diomedi M, et al.
Clin Exp Rheumatol
. 2025 Feb;
43(2):167-177.
PMID: 40018744
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of autoimmune diseases characterised by skeletal muscle inflammation and frequently by other organs involvement, in particular lung and skin, but also joints,...
3.
Giannini M, Bhai S, Boyer O, Cheng K, Johari M, Korsten P, et al.
Clin Exp Rheumatol
. 2025 Feb;
43(2):178-183.
PMID: 39932802
No abstract available.
4.
Hauke M, Kamiya M, Weihl C, Schmidt J
Clin Exp Rheumatol
. 2025 Feb;
43(2):345-353.
PMID: 39907590
Inflammatory myopathies (in short: myositis) display a heterogenic group of rare inflammatory diseases of the skeletal muscle and other organs such as lung, heart and skin. Patients typically display muscular...
5.
Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, Loganathan A, et al.
Arthritis Rheumatol
. 2024 Oct;
PMID: 39467037
Objective: Anti-synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic disease (SARD) with significant heterogeneity and no shared classification criteria. We aimed to identify clinical and serological features associated with...
6.
Koch J, Leha A, Bidner H, Cordts I, Dorst J, GuNTHER R, et al.
Lancet Neurol
. 2024 Oct;
23(11):1133-1146.
PMID: 39424560
Background: Fasudil is a small molecule inhibitor of Rho-associated kinase (ROCK) and is approved for the treatment of subarachnoid haemorrhage. In preclinical studies, fasudil has been shown to attenuate neurodegeneration,...
7.
Zeng R, Schlaeger S, Turk M, Baum T, Deschauer M, Janka R, et al.
Nervenarzt
. 2024 Apr;
95(8):721-729.
PMID: 38683354
Background: Magnetic resonance (MRI) imaging of the skeletal muscles (muscle MRI for short) is increasingly being used in clinical routine for diagnosis and longitudinal assessment of muscle disorders. However, cross-centre...
8.
Zeng R, Schlaeger S, Turk M, Baum T, Deschauer M, Janka R, et al.
Radiologie (Heidelb)
. 2024 Apr;
64(8):653-662.
PMID: 38639916
Background: Magnetic resonance (MRI) imaging of the skeletal muscles (muscle MRI for short) is increasingly being used in clinical routine for diagnosis and longitudinal assessment of muscle disorders. However, cross-centre...
9.
Oldroyd A, Callen J, Chinoy H, Chung L, Fiorentino D, Gordon P, et al.
Nat Rev Rheumatol
. 2024 Mar;
20(5):315.
PMID: 38548933
No abstract available.
10.
Lilleker J, Naddaf E, Saris C, Schmidt J, de Visser M, Weihl C
Neuromuscul Disord
. 2024 Mar;
37:36-51.
PMID: 38522330
Since the publication of the 2013 European Neuromuscular Center (ENMC) diagnostic criteria for Inclusion Body Myositis (IBM), several advances have been made regarding IBM epidemiology, pathogenesis, diagnostic tools, and clinical...